MCID: SJG001
MIFTS: 57

Sjogren's Syndrome malady

Categories: Rare diseases, Immune diseases

Aliases & Classifications for Sjogren's Syndrome

About this section

Aliases & Descriptions for Sjogren's Syndrome:

Name: Sjogren's Syndrome 10 23 12 36 35 65
Sicca Syndrome 10 45 23 65
Keratoconjunctivitis Sicca 23 65
Sjogren-Gougerot Syndrome 45 23
Sjogren Syndrome 10 45
Keratoconjunctivitis Sicca-Xerostomia 23
Secreto-Inhibitor-Xerodermostenosis 23
Dacryosialoadenopathia Atrophicans 23
 
Gougerot-Houwer-Sjogren Syndrome 23
Gougerot-Sjogren Syndrome 23
Sjögren's Syndrome 46
Sjogrens Syndrome 47
Sjögren Syndrome 23
Dry Eye Syndromes 65
Xerodermosteosis 10

Classifications:



External Ids:

Disease Ontology10 DOID:12894
ICD1027 M35.0, M35.00
ICD9CM29 710.2
MeSH36 D012859
UMLS65 C0086981, C1527336

Summaries for Sjogren's Syndrome

About this section
MedlinePlus:35 Sjogren's syndrome is a disease that causes dryness in your mouth and eyes. it can also lead to dryness in other places that need moisture, such as your nose, throat and skin. most people who get sjogren's syndrome are older than 40. nine of 10 are women. sjogren's syndrome is sometimes linked to rheumatic problems such as rheumatoid arthritis. sjogren's syndrome is an autoimmune disease. if you have an autoimmune disease, your immune system, which is supposed to fight disease, mistakenly attacks parts of your own body. in sjogren's syndrome, your immune system attacks the glands that make tears and saliva. it may also affect your joints, lungs, kidneys, blood vessels, digestive organs and nerves. the main symptoms are: dry eyes dry mouth treatment focuses on relieving symptoms. nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary: Sjogren's Syndrome, also known as sicca syndrome, is related to systemic lupus erythematosus and keratoconjunctivitis sicca, and has symptoms including xerostomia, dry skin and keratoconjunctivitis sicca. An important gene associated with Sjogren's Syndrome is TRIM21 (Tripartite Motif Containing 21), and among its related pathways are CXCR3-mediated signaling events and Chemokine Superfamily Pathway: Human/Mouse Ligand-Receptor Interactions. The drugs sodium chloride and sodium chloride granules have been mentioned in the context of this disorder. Affiliated tissues include eye, salivary gland and lung, and related mouse phenotypes are hematopoietic system and immune system.

Disease Ontology:10 A hypersensitivity reaction type II disease that involves attack of immune cells which destroy the exocrine glands that produce tears and saliva.

Genetics Home Reference:23 Sjögren syndrome is a disorder whose main features are dry eyes and a dry mouth. The condition typically develops gradually beginning in middle adulthood, but can occur at any age.

NIH Rare Diseases:45 Sjögren syndrome is an autoimmune disorder in which immune cells attack and destroy the glands that produce tears and saliva. sjögren syndrome is also associated with rheumatic disorders such as rheumatoid arthritis or systemic lupus erythematosus. the hallmark symptoms of the disorder are dry mouth and dry eyes. in addition, sjogren syndrome may cause skin, nose, and vaginal dryness, and may affect other organs of the body including the kidneys, blood vessels, lungs, liver, pancreas, and brain. treatment is symptomatic and supportive and may include moisture replacement therapies, nonsteroidal anti-inflammatory drugs and, in severe cases, corticosteroids or immunosuppressive drugs. last updated: 1/21/2016

NINDS:46 Sj

Wikipedia:68 Sjögren\'s syndrome or Sjögren syndrome (SS) (pronounced /ˈʃoʊɡrᵻn/ or /ˈʃɜːrɡrɛn/ in... more...

Related Diseases for Sjogren's Syndrome

About this section

Diseases in the Sjogren's Syndrome family:

Sjogren's Syndrome, Juvenile, Secondary to Autoimmune Disease

Diseases related to Sjogren's Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 58)
idRelated DiseaseScoreTop Affiliating Genes
1systemic lupus erythematosus26.9APOH, CXCR3, FASLG, SSB, TNFSF13B, TNFSF4
2keratoconjunctivitis sicca21.9APOH, CCL21, CHRM3, CXCL13, CXCR3, FASLG
3marinesco-sjogren syndrome12.3
4short-rib thoracic dysplasia 9 with or without polydactyly10.9
5marshall-smith syndrome10.9
6persistent idiopathic facial pain10.6SPTAN1, TRIM21
7sinoatrial node disease10.5TRIM21, TROVE2
8oculomotor nerve paralysis10.4TRIM21, VIP
9limited scleroderma10.3APOH, SSB, TRIM21
10hiv-110.3
11granulomatous hepatitis10.3APOH, TNFSF13B
12congenital hypomyelination neuropathy10.2TRIM21, TROVE2
13thymic-renal-anal-lung dysplasia10.1CCL21, CXCL13
14paralytic squint10.1HSPG2, TRIM21
15inhalation anthrax10.1HSPG2, TRIM21
16cerebellar angioblastoma10.1APOH, SSB, TNFSF13B
17viral meningitis10.1HSPG2, TNFSF13B, TRIM21
18tenorio syndrome10.0
19mikulicz disease10.0
20rh isoimmunization10.0APOH, TNFSF13B, TRIM21, TROVE2
21opthalmic icthyosis9.9CXCR3, TNFSF13B
22systemic scleroderma9.9
23glomerulonephritis9.8
24lupus erythematosus9.8
25amyloidosis9.8
26keratoconjunctivitis9.8
27kunjin encephalitis9.8CXCR3, TRIM21, TROVE2
28partial fetal alcohol syndrome9.7CHRM3, VIP
29rheumatoid arthritis9.7
30alopecia9.7
31arthritis9.7
32epidermolysis bullosa dystrophica9.7
33hemolytic anemia9.7
34hepatitis9.7
35primary biliary cirrhosis9.7
36colitis9.7
37collagenous colitis9.7
38rheumatic disease9.7
39hepatitis c9.7
40epidermolysis bullosa9.7
41iga glomerulonephritis9.7
42tropical spastic paraparesis9.7
43hyperglobulinemic purpura9.7
44purpura9.7
45mixed connective tissue disease9.7
46cranial nerve palsy9.7
47immune-complex glomerulonephritis9.7
48connective tissue disease9.7
49diffuse infiltrative lymphocytosis syndrome9.7
50autoimmune hemolytic anemia9.7

Comorbidity relations with Sjogren's Syndrome via Phenotypic Disease Network (PDN):


Acute CystitisDeficiency Anemia
HypothyroidismPostinflammatory Pulmonary Fibrosis
OsteoporosisRheumatoid Arthritis
Systemic Lupus Erythematosus

Graphical network of the top 20 diseases related to Sjogren's Syndrome:



Diseases related to sjogren's syndrome

Symptoms for Sjogren's Syndrome

About this section

HPO human phenotypes related to Sjogren's Syndrome:

(show all 73)
id Description Frequency HPO Source Accession
1 xerostomia hallmark (90%) HP:0000217
2 dry skin hallmark (90%) HP:0000958
3 keratoconjunctivitis sicca hallmark (90%) HP:0001097
4 arthritis hallmark (90%) HP:0001369
5 arthralgia hallmark (90%) HP:0002829
6 autoimmunity hallmark (90%) HP:0002960
7 increased antibody level in blood hallmark (90%) HP:0010702
8 furrowed tongue typical (50%) HP:0000221
9 sinusitis typical (50%) HP:0000246
10 visual impairment typical (50%) HP:0000505
11 abnormality of the pharynx typical (50%) HP:0000600
12 diplopia typical (50%) HP:0000651
13 carious teeth typical (50%) HP:0000670
14 acrocyanosis typical (50%) HP:0001063
15 pulmonary infiltrates typical (50%) HP:0002113
16 recurrent respiratory infections typical (50%) HP:0002205
17 pulmonary fibrosis typical (50%) HP:0002206
18 sleep disturbance typical (50%) HP:0002360
19 myalgia typical (50%) HP:0003326
20 paresthesia typical (50%) HP:0003401
21 abnormality of the gastric mucosa typical (50%) HP:0004295
22 abnormality of temperature regulation typical (50%) HP:0004370
23 opacification of the corneal stroma typical (50%) HP:0007759
24 feeding difficulties in infancy typical (50%) HP:0008872
25 corneal erosion typical (50%) HP:0200020
26 renal insufficiency occasional (7.5%) HP:0000083
27 abnormality of the renal tubule occasional (7.5%) HP:0000091
28 proteinuria occasional (7.5%) HP:0000093
29 nephrotic syndrome occasional (7.5%) HP:0000100
30 otitis media occasional (7.5%) HP:0000388
31 conductive hearing impairment occasional (7.5%) HP:0000405
32 epistaxis occasional (7.5%) HP:0000421
33 ptosis occasional (7.5%) HP:0000508
34 ophthalmoparesis occasional (7.5%) HP:0000597
35 photophobia occasional (7.5%) HP:0000613
36 nephrolithiasis occasional (7.5%) HP:0000787
37 diabetes insipidus occasional (7.5%) HP:0000873
38 cutis marmorata occasional (7.5%) HP:0000965
39 urticaria occasional (7.5%) HP:0001025
40 seizures occasional (7.5%) HP:0001250
41 meningitis occasional (7.5%) HP:0001287
42 alopecia occasional (7.5%) HP:0001596
43 pancreatitis occasional (7.5%) HP:0001733
44 splenomegaly occasional (7.5%) HP:0001744
45 thrombocytopenia occasional (7.5%) HP:0001873
46 leukopenia occasional (7.5%) HP:0001882
47 subcutaneous hemorrhage occasional (7.5%) HP:0001933
48 microcytic anemia occasional (7.5%) HP:0001935
49 malabsorption occasional (7.5%) HP:0002024
50 pulmonary hypertension occasional (7.5%) HP:0002092
51 respiratory insufficiency occasional (7.5%) HP:0002093
52 asthma occasional (7.5%) HP:0002099
53 abnormality of the pleura occasional (7.5%) HP:0002103
54 hypercalciuria occasional (7.5%) HP:0002150
55 neurological speech impairment occasional (7.5%) HP:0002167
56 hepatomegaly occasional (7.5%) HP:0002240
57 vasculitis occasional (7.5%) HP:0002633
58 cerebral ischemia occasional (7.5%) HP:0002637
59 lymphoma occasional (7.5%) HP:0002665
60 hypokalemia occasional (7.5%) HP:0002900
61 reduced bone mineral density occasional (7.5%) HP:0004349
62 hemiplegia/hemiparesis occasional (7.5%) HP:0004374
63 abnormality of the sense of smell occasional (7.5%) HP:0004408
64 chronic obstructive pulmonary disease occasional (7.5%) HP:0006510
65 facial palsy occasional (7.5%) HP:0010628
66 arrhythmia occasional (7.5%) HP:0011675
67 abnormal tendon morphology occasional (7.5%) HP:0100261
68 myositis occasional (7.5%) HP:0100614
69 thyroiditis occasional (7.5%) HP:0100646
70 salivary gland neoplasm occasional (7.5%) HP:0100684
71 atelectasis occasional (7.5%) HP:0100750
72 cryoglobulinemia occasional (7.5%) HP:0100778
73 glomerulopathy occasional (7.5%) HP:0100820

UMLS symptoms related to Sjogren's Syndrome:


dryness of eye, pharyngeal dryness, sciatica, muscle cramp, back pain, dacryops

Drugs & Therapeutics for Sjogren's Syndrome

About this section

Drugs for Sjogren's Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 138)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Dexamethasoneapproved, investigationalPhase 4, Phase 2190950-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Baycadron
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
 
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone sodium phosphate
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamethsone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
Ozurdex
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
2
EphedrineapprovedPhase 4, Phase 2, Phase 1447299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
3
Tacrolimusapproved, investigationalPhase 41023104987-11-3445643, 439492, 445647
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
8-DEETHYL-8-[but-3-enyl]-ascomycin
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
FR900506
 
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
Hecoria
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus Hydrate
Tacrolimus anhydrous
Tacrolimus hydrate
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
4
Miconazoleapproved, investigationalPhase 4, Phase 2302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
5
PseudoephedrineapprovedPhase 4, Phase 2, Phase 144790-82-47028
Synonyms:
( )-Pseudoephedrine
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-Psi-ephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-2-methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D-Psi-ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephed 60
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-Psi-ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine Hydrochloride
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrine hydrochloride
Pseudoephedrine sulfate
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Suphedrine
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
trans-Ephedrine
6
PilocarpineapprovedPhase 42454-71-75910
Synonyms:
(+)-Pilocarpine
(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one
(3S,4R)-3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone
(3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone
(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone
(3S-cis)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone
3-Ethyl-4-(3-methyl-3H-imidazol-4-ylmethyl)dihydrofuran-2-one
3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydro-2(3H)-furanone
3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one
3-ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydro-2(3H)-furanone
3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one
54-71-7
91484-73-0
92-13-7
AC1L1J0W
AC1L1LEF
AC1Q6MOP
AI3-50523
AR-1F3128
Adsorbocarpine
Almocarpine
Amistura P
BIDD:GT0217
BPBio1_000548
BRD-K85090592-008-05-2
BSPBio_000498
BSPBio_002191
C07474
CHEBI:39460
CHEBI:8207
CHEMBL550
CID4819
CID5910
D00525
DB01085
DivK1c_000358
EINECS 202-128-4
Epicar
HMS2089K17
HSDB 3163
IDI1_000358
Imidazole-5-butyric acid, alpha-ethyl-beta-(hydroxymethyl)-1-methyl-, gamma-lactone
Isopto carpine
Isoptocarpine
KBio1_000358
KBio2_001587
KBio2_004155
KBio2_006723
KBio3_001691
KBioGR_000956
KBioSS_001587
L001181
LS-187208
LS-7661
Lopac0_000950
Lopac0_000960
Mi-Pilo
Minims Pilocarpine
Miocarpine
MolPort-002-512-506
NCGC00023339-03
NCGC00023339-06
 
NCGC00023339-07
NCGC00023339-08
NCGC00023339-09
NCGC00023339-12
NCGC00023339-13
NCI60_004403
NINDS_000358
NSC5746
Ocu-Carpine
Ocusert
Ocusert P 20
Ocusert Pilo-40
Ocusert pilo
Ocusert pilo-20
Ocusert pilo-20 (TN)
P.V. Carpine Liquifilm
Pilagan
Pilocarpin
Pilocarpine
Pilocarpine (JAN/USP)
Pilocarpine HCl
Pilocarpine Hydrochloride
Pilocarpine Mononitrate, (3S-cis)-Isomer
Pilocarpine [USAN:BAN:JAN]
Pilocarpine chloride
Pilocarpine hydrochloride
Pilocarpine monohydrochloride
Pilocarpine muriate
Pilocarpine nitrate
Pilocarpine, Monohydrochloride, (3S-cis)-Isomer
Pilocarpol
Pilokarpin
Pilokarpin monohydrochloride
Pilokarpol
Piloptic-1
Piloptic-1/2
Piloptic-2
Piloptic-3
Piloptic-4
Piloptic-6
Pilostat
Prestwick0_000449
Prestwick1_000449
Prestwick2_000449
Prestwick3_000449
SDCCGMLS-0003164.P005
SPBio_001287
SPBio_002437
STOCK1N-18408
Salagen
Spectrum2_001284
Spectrum3_000546
Spectrum4_000478
Spectrum5_001379
Spectrum_001107
Spersacarpine
Spersacarpine hydrochloride
Syncarpine
Tocris-0694
UNII-01MI4Q9DI3
ZINC00075008
beta-Pilocarpine hydrochloride
isopilocarpine
nchembio.78-comp9
pilocarpine
7
Cyclophosphamideapproved, investigationalPhase 4, Phase 3264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
8
Calcium carbonateapprovedPhase 4194
Synonyms:
7 Select Antacid
Alka-seltzer Fruit Chews
Alka-seltzer Heartburn Reliefchews
Alka-seltzer Heartburn Reliefchews Cool Mint
Alka-seltzer Heartburn Reliefchews Strawberry
Antacid
Antacid Extra Strength Assorted Berries
Antacid Ultra Strength
Antacid Ultra Strength Assorted Berries
Antacid extra strength
Antacid maximum strength ultra
Being Well Antacid
CaCO3
Calcid ANTACID CALCIUM SUPPLEMENT REGULAR STRENGTH
Calcium Antacid
Calcium Antacid extra strength
Calcium Carbonate
Calcium Carbonate (Antacid)
Calcium Carbonate Chewable Antacid
Calcium Carbonate Extra Strength Antacid
Calcium carbonate
Calcium carbonate (1:1)
Calciumcarbonat
Carbonate de calcium
Carbonato de calcio
Carbonic acid calcium salt (1:1)
Care One Calcium Antacid
Childrens Chewable Antacid
Childrens Pepto
Childrens Stomach Relief
Chooz
D-cal
D-cal Kids
Dg Health Antacid Calcium Supplement
Dg Health Antacid Calcium Supplement regular strength
Dg Health Calcium Antacid
Dg Health Calcium Antacid extra strength
Equaline Antacid
Equaline Antacid regular strength
Equate Antacid
Equate Antacid regular strength
Exchange Select Calcium Antacid
Extra Strength
Extra Strength antacid calcium supplement
First Aid Shot Therapy Upset Stomach Relief
Formu Care Calcium Antacid
Good Sense Antacid
Green Guard Stomach Relief
Health Mart Calcium Antacid
Health Mart Calcium Antacid Assorted Fruit
 
Healthmart Calcium Antacid
Healthy Accents Antacid
Healthy Accents Antacid extra strength
Healthy Mama TAME THE FLAME
Heartburn Relief To Go
His Ulc Mint Blue
Kalziumkarbonat
Kirkland Signature Antacid
Kohlensaurer kalk
Leader Antacid
Leader Antacid Regular Strength
Maximum Strength
Medi First Antacid
Medi First Plus Antacid
Medi-first Antacid
Medi-first Plus Antacid
Medique Alcalak
Medique Ban-acid Maximum Strength 750
Meijer Softchews
Miralac
Miralac Antacid
Moore Medical Antacid
Nutralox
Physicianscare Antacid
Plus Pharma Calcium Antacid
Precipitated calcium carbonate
Regular Strength
Regular Strength Antacid Calcium Supplement
Rexall Antacid
Rx Act Antacid extra strength
Select Brand Antacid Assorted Berries
Sunmark Assorted Berries
Sunmark Calcium Antacid
Sunmark Calcium Antacid REGULAR STRENGTH
Sunmark Calcium Antacid extra strength
Sunmark Calcium Antacid regular strength
Sunmark Smooth Antacid
Titralac
Topcare Antacid Calcium
Topcare Antacid Calcium Extra Strength
Topcare Antacid Calcium Regular Strength
Topcare Antacid Calcium Ultra Strength
Trial Antacid
Tums
Tums Chewy Delights
Tums EX
Tums Smoothies
Tums ULTRA
Tums freshers
Ultrastrength
Welby Health Antacid
e 170
9
PrednisoneapprovedPhase 4126753-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
Juvason
 
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Perrigo Prednisone
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rayos
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
10
GlycerolexperimentalPhase 419156-81-5753
Synonyms:
1,2,3-Trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerine
Glyceritol
Glycerol
 
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
11Neurotransmitter AgentsPhase 414795
12Respiratory System AgentsPhase 4, Phase 2, Phase 3, Phase 13931
13TetrahydrozolinePhase 4, Phase 3, Phase 2, Phase 1542
14Vasoconstrictor AgentsPhase 4, Phase 2, Phase 11303
15Antirheumatic AgentsPhase 4, Phase 3, Phase 2, Phase 18496
16AntacidsPhase 4, Phase 21453
17Anti-Ulcer AgentsPhase 4, Phase 21453
18AntiemeticsPhase 4, Phase 23213
19Dermatologic AgentsPhase 4, Phase 3, Phase 2, Phase 14555
20Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17004
21Antifungal AgentsPhase 4, Phase 23015
22Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 117220
23Adjuvants, ImmunologicPhase 4, Phase 3, Phase 21783
24Cholinergic AgentsPhase 43243
25glucocorticoidsPhase 4, Phase 23896
26HIV Protease InhibitorsPhase 4, Phase 24558
27Ophthalmic SolutionsPhase 4, Phase 3, Phase 2, Phase 11006
28HormonesPhase 4, Phase 211748
29Gastrointestinal AgentsPhase 4, Phase 2, Phase 16401
30Dexamethasone acetatePhase 4, Phase 219091177-87-3
31Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 18478
32Antineoplastic Agents, HormonalPhase 4, Phase 24256
33BB 1101Phase 4, Phase 21909
34Dexamethasone 21-phosphatePhase 4, Phase 21909
35Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 29988
36Hormone AntagonistsPhase 4, Phase 210002
37CyclosporinsPhase 4, Phase 2873
38Calcineurin InhibitorsPhase 4, Phase 21223
39Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 118510
40Immunosuppressive AgentsPhase 4, Phase 3, Phase 2, Phase 110422
41Nasal DecongestantsPhase 4, Phase 2, Phase 1414
42Protease InhibitorsPhase 4, Phase 24558
43Immunologic FactorsPhase 4, Phase 2, Phase 3, Phase 118483
44VaccinesPhase 46085
45Carbopol 940Phase 418
46Castor OilPhase 420
47Calcium, DietaryPhase 44678
48GallopamilPhase 47
49OliveNutraceuticalPhase 4235
50
DehydroepiandrosteronenutraceuticalPhase 4, Phase 28753-43-05881, 9860744
Synonyms:
(+)-Dehydroisoandrosterone
(3-beta)-3-Hydroxyandrost-5-en-17-one
(3beta)-3-hydroxy-Androst-5-en-17-one
(3beta,16alpha)-3,16-dihydroxy-androst-5-en-17-one
17-Chetovis
17-Hormoforin
3-beta-Hydroxy-5-androsten-17-one
3-beta-Hydroxyandrost-5-en-17-one
3b-Hydroxy-D5-androsten-17-one
3b-Hydroxyandrost-5-en-17-one
3beta-Hydroxy-D5-androsten-17-one
3beta-Hydroxyandrost-5-en-17-one
3beta-hydroxy-5-androsten-17-one
3beta-hydroxy-Androst-5-en-17-one
5,6-Dehydroisoandrosterone
5,6-Didehydroisoandrosterone
5-Androsten-3-beta-ol-17-one
5-Androsten-3b-ol-17-one
5-Androsten-3beta-ol-17-one
5-DHEA
5-Dehydro-Epiandrosterone
5-Dehydroepiandrosterone
 
Andrestenol
Androst-5-ene-3b-ol-17-one
Androst-5-ene-3beta-ol-17-one
Androsten-3beta-ol-17-one
Androstenolone
Astenile
D5-Androsten-3b-ol-17-one
D5-Androsten-3beta-ol-17-one
DHA
DHEA
Deandros
Dehydro-epi-androsterone
Dehydroepiandrosterone
Dehydroisoandrosterone
Diandron
Diandrone
Hydroxyandrostenone
Prasterona
Prasterone
Prasteronum
Prestara
Psicosterone
trans-Dehydroandrosterone

Interventional clinical trials:

(show top 50)    (show all 128)
idNameStatusNCT IDPhase
1Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid InterventionCompletedNCT00631358Phase 4
2Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsCompletedNCT01850979Phase 4
3A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA StudyCompletedNCT02049112Phase 4
4A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy TreatmentCompletedNCT00438048Phase 4
5Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on FatigueActive, not recruitingNCT00543166Phase 4
6Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseaseActive, not recruitingNCT02004067Phase 4
7Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesActive, not recruitingNCT01151644Phase 4
8Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's SyndromeNot yet recruitingNCT02370550Phase 4
9Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein LevelsTerminatedNCT00578578Phase 4
10Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's SyndromeCompletedNCT01601028Phase 3
11Hydroxychloroquine Versus Placebo in Primary Sjögren's SyndromeCompletedNCT00632866Phase 3
12Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye SyndromeCompletedNCT00025818Phase 3
13Tolerance and Efficacy of Rituximab in Sjogren's DiseaseCompletedNCT00740948Phase 2, Phase 3
14Preventive IVIG Therapy for Congenital Heart BlockCompletedNCT00460928Phase 2, Phase 3
15Laser Therapy to Treat the Dry Mouth of Sjogren's SyndromeRecruitingNCT02066896Phase 3
16Efficacy and Safety of Abatacept in Patients With Primary Sjögren's SyndromeRecruitingNCT02067910Phase 3
17Efficacy of Tocilizumab in Primary Sjögren's Syndrome.RecruitingNCT01782235Phase 2, Phase 3
18A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeRecruitingNCT02503163Phase 3
19An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeRecruitingNCT02503176Phase 3
20A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeRecruitingNCT02503189Phase 3
21Treatment of Salivary Gland Hypofunction With Neuro- ElectrostimulationRecruitingNCT01174329Phase 2, Phase 3
22WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated VasculitidesActive, not recruitingNCT00349674Phase 3
23Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous BloodEnrolling by invitationNCT02153515Phase 3
24Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry EyeNot yet recruitingNCT02257957Phase 3
25A Clinical Trial for CTD-ILD TreatmentTerminatedNCT01424033Phase 2, Phase 3
26Effect of Saliva Substitutes on Dental Hard Tissues in SituTerminatedNCT01165970Phase 2, Phase 3
27Low Dose Cyclosporin A in Primary Sjögren SyndromeCompletedNCT01693393Phase 2
28A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's SyndromeCompletedNCT00852839Phase 2
29Etanercept Therapy for Sjogren's SyndromeCompletedNCT00001954Phase 2
30Pilot Study of Thalidomide to Treat Sjogren's SyndromeCompletedNCT00001599Phase 2
31DHEA Treatment for Sjogren's SyndromeCompletedNCT00001598Phase 2
32Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's SyndromeCompletedNCT01160666Phase 2
33Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's SyndromeCompletedNCT00391924Phase 2
34Efficacy and Safety of Belimumab in Primary Sjögren's SyndromeCompletedNCT01008982Phase 2
35Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's SyndromeCompletedNCT00637793Phase 2
36Effect of B-cell Depletion in Patients With Primary Sjögren's SyndromeCompletedNCT00426543Phase 2
37Exploratory Study for Dry Mouth in Patients With Sjögren’s SyndromeCompletedNCT00233363Phase 2
38Rituximab Treatment in Sjogren's SyndromeCompletedNCT00363350Phase 1, Phase 2
39An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal WetnessCompletedNCT01369589Phase 1, Phase 2
40Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens SyndromeCompletedNCT00683345Phase 2
41Green Tea Lozenges for the Management of Dry MouthCompletedNCT01647737Phase 1, Phase 2
42Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry EyeCompletedNCT01393132Phase 2
43Treatment of Dry Eye Syndrome With Cyclosporin A Eye DropsCompletedNCT00001731Phase 2
44Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's SyndromeRecruitingNCT02291029Phase 2
45Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's SyndromeRecruitingNCT02110446Phase 2
46Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)RecruitingNCT00953485Phase 1, Phase 2
47A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's SyndromeRecruitingNCT02701985Phase 2
48A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's SyndromeRecruitingNCT02334306Phase 2
49UCB Proof of Concept Study in Patients With Primary Sjogren's SyndromeRecruitingNCT02610543Phase 2
50A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's SyndromeRecruitingNCT02464319Phase 2

Search NIH Clinical Center for Sjogren's Syndrome

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: sjogren's syndrome

Genetic Tests for Sjogren's Syndrome

About this section

Anatomical Context for Sjogren's Syndrome

About this section

MalaCards organs/tissues related to Sjogren's Syndrome:

33
Eye, Salivary gland, Lung, Skin, Kidney, Liver, Brain

Animal Models for Sjogren's Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Sjogren's Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.6CXCL13, CXCR3, FASLG, HSPG2, SSB, TNFSF13B
2MP:00053876.9CXCL13, CXCR3, FASLG, HSPG2, SSB, TNFSF13B

Publications for Sjogren's Syndrome

About this section

Articles related to Sjogren's Syndrome:

(show top 50)    (show all 260)
idTitleAuthorsYear
1
Hypokalemic paralysis as a primary presentation of Fanconi's syndrome and distal renal tubular acidosis in a patient with primary Sjogren's syndrome. (26053828)
2015
2
Microscopic polyangiitis associated with primary biliary cirrhosis, Sjogren's syndrome and Hashimoto's thyroiditis. (25758890)
2015
3
Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations. (25886059)
2015
4
Porphyria cutanea tarda and Sjogren's syndrome. (25054769)
2014
5
Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. (23968620)
2014
6
Classification criteria for Sjogren's syndrome: nothing ever stands still! (24092418)
2014
7
Pyoderma gangrenosum: intractable leg ulcers in Sjogren's syndrome. (25224774)
2014
8
Chemokine receptor 5 I932 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations. (24599359)
2014
9
Annular subacute cutaneous lupus erythematosus lesions and polymyositis onset in a patient with primary Sjogren's syndrome: how should this unusual association be classified? (23358869)
2013
10
The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis. (24307005)
2013
11
Hypokalemic rhabdomyolysis: an unusual presentation of Sjogren's syndrome. (24165505)
2013
12
Polymicrobial and microsporidial keratitis in a patient using Boston scleral contact lens for Sjogren's syndrome and ocular cicatricial pemphigoid. (23123433)
2013
13
Sjogren's syndrome with acute cerebellar ataxia and massive lymphadenopathy : a case report. (24030041)
2013
14
Sjogren's syndrome with trigeminal neuropathy: motor involvement. (23703941)
2013
15
Toxic epitheliopathy from a single application of preservative free oxybuprocaine (0.4%) in a patient with Sjogren's syndrome. (24038291)
2013
16
High prevalence of autoimmune thyroid disease in subjects with sicca symptoms without Sjogren's syndrome. (23382358)
2013
17
The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome. (24080911)
2013
18
Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: an animal study. (23333492)
2013
19
Autoantibodies and Sjogren's Syndrome in multiple sclerosis, a reappraisal. (23776474)
2013
20
Severe excessive dynamic airway collapse in a patient with primary Sjogren's syndrome. (24381188)
2013
21
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. (24347569)
2013
22
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. (23264342)
2013
23
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. (23884468)
2013
24
Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye. (23001257)
2012
25
Sialochemistry and cortisol levels in patients with Sjogren's syndrome. (22050355)
2012
26
Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome. (22871954)
2012
27
Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome. (20215141)
2010
28
The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome. (19952070)
2010
29
Genetic dissociation of dacryoadenitis and sialadenitis in a Sjogren's syndrome mouse model with common and different susceptibility gene loci. (19218603)
2009
30
Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. (19181658)
2009
31
Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome. (19833746)
2009
32
Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. (18809413)
2008
33
Central nervous system lymphoma in a patient with Sjogren's syndrome and autoimmune thyroiditis (Hashimoto's thyroiditis). (16941199)
2007
34
Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab. (15958765)
2005
35
Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome. (16014536)
2005
36
A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjogren's syndrome. (15725576)
2005
37
Osteomalacia revealing Sjogren's syndrome. (16226045)
2005
38
Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma. (15576414)
2005
39
Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome. (15328426)
2004
40
Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with primary Sjogren's syndrome. (15163114)
2004
41
Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome. (15593200)
2004
42
Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome. (15448217)
2004
43
Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. (12741480)
2003
44
Prophylactic antibiotics in recurrent parotitis in a patient with Sjogren's syndrome. (10357124)
1999
45
Distinct alterations in lineage committed progenitor cells exist in the peripheral blood of patients with rheumatoid arthritis and primary Sjogren's syndrome. (8832979)
1996
46
Therapeutic effect of ethamsylate in a case of hyperglobulinemic purpura associated with Sjogren's syndrome. (8833011)
1996
47
Detection of cytomegalovirus and Epstein-Barr virus in labial salivary glands in Sjogren's syndrome and non-specific sialadenitis. (7473264)
1995
48
Detection of Epstein-Barr virus antigens and DNA in major and minor salivary glands using immunocytochemistry and polymerase chain reaction: possible relationship with Sjogren's syndrome. (1851828)
1991
49
Sjogren's syndrome and keratoconjunctivitis sicca. (2055025)
1991
50
Hashimoto's thyroiditis, pernicious anemia, Sjogren's syndrome, and CRST syndrome -- a case report. (6894462)
1981

Variations for Sjogren's Syndrome

About this section

Expression for genes affiliated with Sjogren's Syndrome

About this section
Search GEO for disease gene expression data for Sjogren's Syndrome.

Pathways for genes affiliated with Sjogren's Syndrome

About this section

Pathways related to Sjogren's Syndrome according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.4CXCL13, CXCR3
2
Show member pathways
8.9CCL21, CXCL13, CXCR3
3
Show member pathways
8.0CCL21, CXCL13, CXCR3, FASLG, TNFSF13B, TNFSF4

GO Terms for genes affiliated with Sjogren's Syndrome

About this section

Biological processes related to Sjogren's Syndrome according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of endothelial cell proliferationGO:000193710.1APOH, CXCR3
2positive regulation of chemotaxisGO:00509219.8CCL21, CXCR3
3negative regulation of angiogenesisGO:00165259.8APOH, CXCR3, FASLG
4cell surface receptor signaling pathwayGO:00071669.4CXCL13, CXCR3, FASLG
5chemokine-mediated signaling pathwayGO:00700988.9CCL21, CXCL13, CXCR3
6immune responseGO:00069558.8CCL21, FASLG, TNFSF13B, TNFSF4
7G-protein coupled receptor signaling pathwayGO:00071868.1CCL21, CHRM3, CXCL13, CXCR3, VIP

Sources for Sjogren's Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet